Related Experiment Videos
[Complications following axillary dissection for breast carcinoma]
M S van Dam1, A Hennipman, J T de Kruif
1Academisch Ziekenhuis, afd. Chirurgie, Utrecht.
Nederlands Tijdschrift Voor Geneeskunde
|November 13, 1993
Summary
Routine axillary dissection for breast cancer often damages intercostobrachial nerves, causing arm pain and sensory loss in many patients. Preserving these nerves may reduce post-operative morbidity.
Area of Science:
- Oncology
- Surgical Pathology
- Pain Management
Background:
- Axillary dissection is crucial for breast cancer staging and regional control.
- This procedure can lead to significant morbidity, including post-operative pain.
- Damage to intercostobrachial nerves is increasingly recognized as a cause of arm pain after surgery.
Purpose of the Study:
- To evaluate the morbidity associated with routine axillary dissection.
- To assess the incidence and severity of post-axillary dissection pain.
- To determine the impact of intercostobrachial nerve transection on patient outcomes.
Main Methods:
- Interview and clinical examination of 71 women (75 axillae) who underwent axillary dissection for breast cancer.
- Data collection on sensory deficits, pain (using NRS score), seroma, lymphedema, and shoulder function.
- Correlation of symptoms with intercostobrachial nerve status.
Main Results:
- Sensory deficit in the axilla/arm was present in almost all patients.
- 35% of patients experienced arm pain, consistent with intercostobrachial nerve innervation.
- Moderate to severe pain (NRS ≥ 5) occurred in one-third of those with pain.
- Seroma and lymphedema were observed in 21 patients; reduced shoulder abduction in 6.
- Most complaints were non-invalidating (48 patients), but 10 reported moderate invalidity.
Conclusions:
- Routine transection of intercostobrachial nerves during axillary dissection leads to sensory changes and potential pain.
- Preserving one or two intercostobrachial nerves should be considered to minimize operative morbidity.
- Histological examination of axillary nodes remains vital for staging and adjuvant therapy decisions.